Introduction: Open fetal myelomeningocele (fMMC) repair is nowadays a therapeutic option in selected cases. We aimed to evaluate changes in maternal and fetal outcome after fMMC repair during the first 8 years of experience at a tertiary referral fetal medicine center in Switzerland. -Materials and Methods: Between 2010 and 2018, fMMC repair and delivery of the neonate via planned cesarean section was performed in 67 cases. Cases were retrospectively stratified into 2 groups: a “training phase” (TP) with supervision from an external surgeon during 11 operations (2010–2014, 15 cases) followed by an “experienced phase” (EP, 2014–2018, 52 cases); each phase lasted about 4 years. Both phases were compared with regard to various maternal and fetal outcome parameters. Results: Analyses did not reveal differences between TP and EP in major outcome parameters such as gestational age at delivery, chorionic membrane separation, or the incidence of placental abruption. Although more complex surgical techniques were applied in EP (e.g., dermal closure using a rotational flap), surgery time was not different from TP. At the same time, surgical complications such as oligohydramnios (27 vs. 8%, p = 0.046) with MRI-confirmed leakage (13 vs. 4%, nonsignificant) and subchorionic hematoma (20 vs. 2%, p = 0.009) were less common in EP than TP. Conclusions: This study shows that the level of competence at our center with regard to major perinatal outcome parameters was already high in the first years of fMMC repair. However, more complex surgical techniques and significantly less minor complications were observed during the most recent years.

1.
Adzick
NS
,
Thom
EA
,
Spong
CY
,
Brock
JW
 3rd
,
Burrows
PK
,
Johnson
MP
, et al.;
MOMS Investigators
.
A randomized trial of prenatal versus postnatal repair of myelomeningocele
.
N Engl J Med
.
2011
Mar
;
364
(
11
):
993
1004
.
[PubMed]
0028-4793
2.
Moldenhauer
JS
,
Soni
S
,
Rintoul
NE
,
Spinner
SS
,
Khalek
N
,
Martinez-Poyer
J
, et al.
Fetal myelomeningocele repair: the post-MOMS experience at the Children’s Hospital of Philadelphia
.
Fetal Diagn Ther
.
2015
;
37
(
3
):
235
40
.
[PubMed]
1015-3837
3.
Moldenhauer
JS
,
Adzick
NS
.
Fetal surgery for myelomeningocele: After the Management of Myelomeningocele Study (MOMS)
.
Semin Fetal Neonatal Med
.
2017
Dec
;
22
(
6
):
360
6
.
[PubMed]
1744-165X
4.
Johnson
MP
,
Bennett
KA
,
Rand
L
,
Burrows
PK
,
Thom
EA
,
Howell
LJ
,
Farrell
JA
,
Dabrowiak
ME
,
Brock
JW
, 3rd
,
Farmer
DL
,
Adzick
NS
, Management of Myelomeningocele Study I: The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol
2016
;215:778 e771-778 e779.
5.
Meuli
M
,
Moehrlen
U
.
Fetal surgery for myelomeningocele is effective: a critical look at the whys
.
Pediatr Surg Int
.
2014
Jul
;
30
(
7
):
689
97
.
[PubMed]
0179-0358
6.
Soni
S
,
Moldenhauer
JS
,
Spinner
SS
,
Rendon
N
,
Khalek
N
,
Martinez-Poyer
J
,
Johnson
MP
,
Adzick
NS
:
Chorioamniotic membrane separation and preterm premature rupture of membranes complicating in utero myelomeningocele repair.
Am J Obstet Gynecol
2016
;214:647 e641-647.
7.
Zamłyński
J
,
Olejek
A
,
Koszutski
T
,
Ziomek
G
,
Horzelska
E
,
Gajewska-Kucharek
A
, et al.
Comparison of prenatal and postnatal treatments of spina bifida in Poland—a non-randomized, single-center study
.
J Matern Fetal Neonatal Med
.
2014
Sep
;
27
(
14
):
1409
17
.
[PubMed]
1476-7058
8.
Belfort
M
,
Deprest
J
,
Hecher
K
.
Current controversies in prenatal diagnosis 1: in utero therapy for spina bifida is ready for endoscopic repair
.
Prenat Diagn
.
2016
Dec
;
36
(
13
):
1161
6
.
[PubMed]
0197-3851
9.
Winder
FM
,
Vonzun
L
,
Meuli
M
,
Moehrlen
U
,
Mazzone
L
,
Krahenmann
F
, et al.
Maternal Complications following Open Fetal Myelomeningocele Repair at the Zurich Center for Fetal Diagnosis and Therapy
.
Fetal Diagn Ther
.
2018
;
•••
:
1
6
.
[PubMed]
1015-3837
10.
Vonzun
L
,
Winder
FM
,
Meuli
M
,
Moerlen
U
,
Mazzone
L
,
Kraehenmann
F
, et al.
Prenatal Sonographic Head Circumference and Cerebral Ventricle Width Measurements Before and After Open Fetal Myelomeningocele Repair - Prediction of Shunting During the First Year of Life
.
Ultraschall Med
.
2018
Oct
.
[PubMed]
0172-4614
11.
Bennett
KA
,
Carroll
MA
,
Shannon
CN
,
Braun
SA
,
Dabrowiak
ME
,
Crum
AK
, et al.
Reducing perinatal complications and preterm delivery for patients undergoing in utero closure of fetal myelomeningocele: further modifications to the multidisciplinary surgical technique
.
J Neurosurg Pediatr
.
2014
Jul
;
14
(
1
):
108
14
.
[PubMed]
1933-0707
12.
Moron
AF
,
Barbosa
MM
,
Milani
H
,
Sarmento
SG
,
Santana
E
,
Suriano
IC
, et al.
Perinatal outcomes after open fetal surgery for myelomeningocele repair: a retrospective cohort study
.
BJOG
.
2018
;
125
(
10
):
1280
6
. 1470-0328
13.
Morris
RK
,
Selman
TJ
,
Harbidge
A
,
Martin
WI
,
Kilby
MD
.
Fetoscopic laser coagulation for severe twin-to-twin transfusion syndrome: factors influencing perinatal outcome, learning curve of the procedure and lessons for new centres
.
BJOG
.
2010
Oct
;
117
(
11
):
1350
7
.
[PubMed]
1470-0328
14.
Habli
M
,
Bombrys
A
,
Lewis
D
,
Lim
FY
,
Polzin
W
,
Maxwell
R
,
Crombleholme
T
:
Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience.
Am J Obstet Gynecol
2009
;201:417 e411-417.
15.
Ortiz
JU
,
Eixarch
E
,
Peguero
A
,
Lobmaier
SM
,
Bennasar
M
,
Martinez
JM
, et al.
Chorioamniotic membrane separation after fetoscopy in monochorionic twin pregnancy: incidence and impact on perinatal outcome
.
Ultrasound Obstet Gynecol
.
2016
Mar
;
47
(
3
):
345
9
.
[PubMed]
0960-7692
16.
Chalouhi
GE
,
Essaoui
M
,
Stirnemann
J
,
Quibel
T
,
Deloison
B
,
Salomon
L
, et al.
Laser therapy for twin-to-twin transfusion syndrome (TTTS)
.
Prenat Diagn
.
2011
Jul
;
31
(
7
):
637
46
.
[PubMed]
0197-3851
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.